Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Clark

Showing results (281-290 of 297) with videos related to

Pageof 30
Sort By:
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, O G Ottmann, M Deininger, et al.
Leukemia|September 15, 2016
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemiaA K Burnett, N H Russell, R K Hills, et al.
Annals of Surgery|June 1, 1981
Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservationR E Clark, I Y Christlieb, T B Ferguson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2020
Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot TrialS Hassan, S J Seung, R E Clark, et al.
Leukemia|June 16, 2012
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-upR A Larson, A Hochhaus, T P Hughes, et al.
British Journal of Haematology|March 1, 1997
Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cellsE A Chalmers, I M Franklin, S M Kelsey, et al.
Bone Marrow Transplantation|November 12, 2014
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)E Snarski, J A Snowden, M C Oliveira, et al.
Blood|November 8, 2001
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion proteinR E Clark, I A Dodi, S C Hill, et al.
British Journal of Haematology|September 30, 1998
Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cellsI O Singer, I M Franklin, R E Clark, et al.
Leukemia|April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaJ L Steegmann, M Baccarani, M Breccia, et al.
Pageof 30

Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, O G Ottmann, M Deininger, et al.
Leukemia|September 15, 2016
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemiaA K Burnett, N H Russell, R K Hills, et al.
Annals of Surgery|June 1, 1981
Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservationR E Clark, I Y Christlieb, T B Ferguson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2020
Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot TrialS Hassan, S J Seung, R E Clark, et al.
Leukemia|June 16, 2012
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-upR A Larson, A Hochhaus, T P Hughes, et al.
British Journal of Haematology|March 1, 1997
Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cellsE A Chalmers, I M Franklin, S M Kelsey, et al.
Bone Marrow Transplantation|November 12, 2014
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)E Snarski, J A Snowden, M C Oliveira, et al.
Blood|November 8, 2001
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion proteinR E Clark, I A Dodi, S C Hill, et al.
British Journal of Haematology|September 30, 1998
Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cellsI O Singer, I M Franklin, R E Clark, et al.
Leukemia|April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaJ L Steegmann, M Baccarani, M Breccia, et al.
Pageof 30